GLP-1 may slow biological aging
A recent study suggests that drugs targeting the hormone GLP-1 could decelerate cellular aging processes. Researchers observed that GLP-1 analogues improved markers of metabolic health and reduced age‑related tissue damage in animal models. The findings raise the possibility that existing GLP‑1 therapies might have broader longevity benefits, though human trials are still needed for future research.